PubRank

S Seiter

Author PubWeight™ 23.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 2000 9.70
2 Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study. J Clin Oncol 1997 1.20
3 Association between the rat homologue of CO-029, a metastasis-associated tetraspanin molecule and consumption coagulopathy. J Cell Biol 1998 1.13
4 Cloning and functional characterization of a new phosphatidyl-inositol anchored molecule of a metastasizing rat pancreatic tumor. Oncogene 1998 1.07
5 Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J Pathol 1996 1.03
6 Dacarbazine and interferon alpha with or without interleukin 2 in metastatic melanoma: a randomized phase III multicentre trial of the Dermatologic Cooperative Oncology Group (DeCOG). Br J Cancer 2001 1.02
7 CD44 variant isoforms on blood leukocytes in chronic inflammatory bowel disease and other systemic autoimmune diseases. Lab Invest 1999 0.99
8 Treatment with an anti-CD44v10-specific antibody inhibits the onset of alopecia areata in C3H/HeJ mice. J Invest Dermatol 2000 0.87
9 Interlaboratory evaluation of a new reverse transcriptase polymerase chain reaction-based enzyme-linked immunosorbent assay for the detection of circulating melanoma cells: a multicenter study of the Dermatologic Cooperative Oncology Group. J Clin Oncol 2001 0.87
10 Metastasis-association of the rat ortholog of the human epithelial glycoprotein antigen EGP314. Oncogene 1999 0.84
11 Cloning of the human homologue of the metastasis-associated rat C4.4A. Gene 2001 0.84
12 Efficacy of local versus systemic application of antibody-cytokine fusion proteins in tumor therapy. Clin Cancer Res 2001 0.82
13 Functional activity of murine CD44 variant isoforms in allergic and delayed type hypersensitivity. Immunol Lett 1997 0.81
14 Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-gamma. Int J Cancer 1999 0.80
15 CD2-mediated CD59 stimulation in keratinocytes results in secretion of IL-1alpha, IL-6, and GM-CSF: implications for the interaction of keratinocytes with intraepidermal T lymphocytes. Int J Mol Med 1999 0.79
16 CD44v10 expression in the mouse and functional activity in delayed type hypersensitivity. J Cell Physiol 1997 0.79
17 Treatment of progressive pigmented purpura with oral bioflavonoids and ascorbic acid: an open pilot study in 3 patients. J Am Acad Dermatol 1999 0.77
18 Transient absence of CD44 expression and delay in development by anti-CD44 treatment during ontogeny: a surrogate of an inducible knockout? Cell Growth Differ 1997 0.75
19 [Ocular manifestation of progressive essential telangiectases]. J Fr Ophtalmol 2001 0.75
20 Interferon-alpha-associated development of bullous lesions in mycosis fungoides. Dermatology 2000 0.75
21 An oculocutaneous presentation of essential progressive telangiectasia. Br J Dermatol 1999 0.75